Numinus – Approved to Use Psilocybin for the First Time Outside of Clinical Trials
Joe Flanders, PhD, OPQ, Vice President, Psychology at Numinus discusses that end-of-life patients in Canada now have psilocybin-assisted therapy as a to...
5304 articles
Joe Flanders, PhD, OPQ, Vice President, Psychology at Numinus discusses that end-of-life patients in Canada now have psilocybin-assisted therapy as a to...
Barb Dehn, a practicing Women’s Health Nurse Practitioner discusses vaginal health, yeast infections, and the latest treatment advancements.
Lisa Marie Clinton, founder of avail ® and Managing Director of avail Support at CentralReach, the leading provider of Autism and IDD care software, di...
Kendra Grubb, M.D., surgical director of the Structural Heart and Valve Center at Emory University in Atlanta, and co-principal investigator in the Opti...
Returning guest Terence Rooney, M.D., Vice President, Rheumatology and Maternal-Fetal Immunology Disease Area Leader for the Immunology Therapeutic Area...
Jim Woody, CEO of 180 Life Sciences Corp., a newly formed clinical-stage biotech company focused on novel drugs for unmet needs in inflammatory diseases...
Keith Palmer, Worldwide Vice President, Hip Reconstruction, DePuy Synthes discusses the changing patient population and what this means for procedures l...
Emily Kraus, MD, pediatric sports medicine specialist at Stanford Children's Health and director of the Female Athlete Science and Translational Researc...
Joshua McClure is CEO, Co-founder, and Co-inventor of Maxwell Biosciences, a preclinical drug platform company that develops biomimetic therapeutics - s...
Johnny Bench, former Cincinnati Reds Catcher and Baseball Hall of Fame Player who was diagnosed with basal cell carcinoma (BCC) the most common type of ...